{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:14:11Z","timestamp":1788779651074,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Development Fund, Macau SAR","award":["File no. 0002\/2025\/NRP"],"award-info":[{"award-number":["File no. 0002\/2025\/NRP"]}]},{"DOI":"10.13039\/501100004733","name":"University of Macau","doi-asserted-by":"crossref","award":["UMDF-TISF-I\/2026\/019\/ICMS; SRG2025-00027-ICMS"],"award-info":[{"award-number":["UMDF-TISF-I\/2026\/019\/ICMS; SRG2025-00027-ICMS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06060-9","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:34:13Z","timestamp":1782218053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of drug-eluting stent in Chinese population with or without diabetes: a multi-center registry study"],"prefix":"10.1186","volume":"26","author":[{"given":"Shining","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"2","key":"6060_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2991\/jegh.k.201217.001","volume":"11","author":"U Ralapanawa","year":"2021","unstructured":"Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health. 2021;11(2):169\u201377. https:\/\/doi.org\/10.2991\/jegh.k.201217.001. Published Online First: 20210107.","journal-title":"J Epidemiol Glob Health"},{"issue":"10","key":"6060_CR2","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJMoa067193","volume":"356","author":"GW Stone","year":"2007","unstructured":"Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356(10):998\u20131008. https:\/\/doi.org\/10.1056\/NEJMoa067193. Published Online First: 20070212.","journal-title":"N Engl J Med"},{"issue":"7","key":"6060_CR3","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/s0735-1097(98)00467-7","volume":"32","author":"S Elezi","year":"1998","unstructured":"Elezi S, Kastrati A, Pache J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol. 1998;32(7):1866\u201373. https:\/\/doi.org\/10.1016\/s0735-1097(98)00467-7.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"6060_CR4","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1161\/01.Cir.0000069331.67148.2f","volume":"107","author":"JE Sousa","year":"2003","unstructured":"Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology: drug-eluting stents: part II. Circulation. 2003;107(18):2383\u20139. https:\/\/doi.org\/10.1161\/01.Cir.0000069331.67148.2f.","journal-title":"Circulation"},{"issue":"8","key":"6060_CR5","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.jacc.2004.10.075","volume":"45","author":"JB Hermiller","year":"2005","unstructured":"Hermiller JB, Raizner A, Cannon L, et al. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol. 2005;45(8):1172\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2004.10.075.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"6060_CR6","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ahj.2007.06.005","volume":"154","author":"R Iijima","year":"2007","unstructured":"Iijima R, Ndrepepa G, Mehilli J, et al. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J. 2007;154(4):688\u201393. https:\/\/doi.org\/10.1016\/j.ahj.2007.06.005.","journal-title":"Am Heart J"},{"issue":"12","key":"6060_CR7","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.amjcard.2019.03.019","volume":"123","author":"AM Mahajan","year":"2019","unstructured":"Mahajan AM, Claessen BE, Chandrasekhar J, et al. Outcomes by gender and ethnicity after percutaneous coronary intervention. Am J Cardiol. 2019;123(12):1941\u201348. https:\/\/doi.org\/10.1016\/j.amjcard.2019.03.019. Published Online First: 20190319.","journal-title":"Am J Cardiol"},{"issue":"5","key":"6060_CR8","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/ejcts\/ezu276","volume":"47","author":"SS Baig","year":"2015","unstructured":"Baig SS, Altman DG, Taggart DP. Major geographical variations in elective coronary revascularization by stents or surgery in England. Eur J Cardiothorac Surg. 2015;47(5):855\u20139. https:\/\/doi.org\/10.1093\/ejcts\/ezu276. Published Online First: 20140717.","journal-title":"Eur J Cardiothorac Surg"},{"key":"6060_CR9","doi-asserted-by":"publisher","unstructured":"Havranek EP, Mujahid MS, Barr DA, et al. Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015;132(9):873\u201398. https:\/\/doi.org\/10.1161\/cir.0000000000000228. Published Online First: 20150803.","DOI":"10.1161\/cir.0000000000000228"},{"key":"6060_CR10","doi-asserted-by":"publisher","unstructured":"Sotomi Y, Onuma Y, Cavalcante R, et al. Geographical difference of the interaction of sex with treatment strategy in patients with multivessel disease and left main disease: a meta-analysis from SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) randomized controlled trials. Circ Cardiovasc Interv. 2017;10(5). https:\/\/doi.org\/10.1161\/circinterventions.117.005027.","DOI":"10.1161\/circinterventions.117.005027"},{"issue":"18","key":"6060_CR11","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1053\/euhj.2001.2583","volume":"22","author":"RP Giugliano","year":"2001","unstructured":"Giugliano RP, Llevadot J, Wilcox RG, et al. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II. Eur Heart J. 2001;22(18):1702\u201315. https:\/\/doi.org\/10.1053\/euhj.2001.2583.","journal-title":"Eur Heart J"},{"issue":"3","key":"6060_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ccl.2014.04.001","volume":"32","author":"D Aronson","year":"2014","unstructured":"Aronson D, Edelman ER. Coronary artery disease and diabetes mellitus. Cardiol Clin. 2014;32(3):439\u201355. https:\/\/doi.org\/10.1016\/j.ccl.2014.04.001. Published Online First: 2014061.","journal-title":"Cardiol Clin"},{"issue":"4","key":"6060_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.18502\/jthc.v17i4.11609","volume":"17","author":"MJ Zibaeenezhad","year":"2022","unstructured":"Zibaeenezhad MJ, Sayadi M, Mohammadi SS, et al. The impact of diabetes mellitus on clinical outcomes after percutaneous coronary intervention with different stent sizes. J Tehran Heart Cent. 2022;17(4):207\u201314. https:\/\/doi.org\/10.18502\/jthc.v17i4.11609.","journal-title":"J Tehran Heart Cent"},{"issue":"8","key":"6060_CR14","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.jacc.2003.04.004","volume":"43","author":"R Mehran","year":"2004","unstructured":"Mehran R, Dangas GD, Kobayashi Y, et al. Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol. 2004;43(8):1348\u201354. https:\/\/doi.org\/10.1016\/j.jacc.2003.04.004.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"6060_CR15","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.jcin.2018.09.033","volume":"11","author":"M Konigstein","year":"2018","unstructured":"Konigstein M, Ben-Yehuda O, Smits PC, et al. Outcomes among diabetic patients undergoing percutaneous coronary intervention with contemporary drug-eluting stents: analysis from the BIONICS randomized trial. JACC Cardiovasc Interv. 2018;11(24):2467\u201376. https:\/\/doi.org\/10.1016\/j.jcin.2018.09.033.","journal-title":"JACC Cardiovasc Interv"},{"issue":"20","key":"6060_CR16","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.jacc.2014.01.064","volume":"63","author":"E Kedhi","year":"2014","unstructured":"Kedhi E, G\u00e9n\u00e9reux P, Palmerini T, et al. Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials. J Am Coll Cardiol. 2014;63(20):2111\u201318. https:\/\/doi.org\/10.1016\/j.jacc.2014.01.064. [published Online First: 20140313].","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6060_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/1479164115592252","volume":"12","author":"G De Luca","year":"2015","unstructured":"De Luca G, Sauro R, Capasso M, et al. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction. Diab Vasc Dis Res. 2015;12(5):306\u201314. https:\/\/doi.org\/10.1177\/1479164115592252. [published Online First: 20150706].","journal-title":"Diab Vasc Dis Res"},{"issue":"5","key":"6060_CR18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ahj.2012.02.014","volume":"163","author":"M Billinger","year":"2012","unstructured":"Billinger M, R\u00e4ber L, Hitz S, et al. Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents. Am Heart J. 2012;163(5):876\u2013e862. https:\/\/doi.org\/10.1016\/j.ahj.2012.02.014.","journal-title":"Am Heart J"},{"issue":"9596","key":"6060_CR19","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"issue":"9","key":"6060_CR20","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jcin.2010.03.021","volume":"3","author":"PB Berger","year":"2010","unstructured":"Berger PB, Kleiman NS, Pencina MJ, et al. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv. 2010;3(9):920\u20137. https:\/\/doi.org\/10.1016\/j.jcin.2010.03.021.","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"6060_CR21","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00380-015-0741-6","volume":"31","author":"IS Kang","year":"2016","unstructured":"Kang IS, Shehata I, Shin D-H, et al. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation. Heart Vessels. 2016;31(9):1405\u201311. https:\/\/doi.org\/10.1007\/s00380-015-0741-6.","journal-title":"Heart Vessels"},{"issue":"3","key":"6060_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.4244\/eijy15m06_02","volume":"12","author":"CK Naber","year":"2016","unstructured":"Naber CK, Pyxaras SA, Nef H, et al. Final results of a self-apposing paclitaxel-eluting stent for the percutaneous treatment of de novo lesions in native bifurcated coronary arteries study. EuroIntervention. 2016;12(3):356\u20138. https:\/\/doi.org\/10.4244\/eijy15m06_02.","journal-title":"EuroIntervention"},{"issue":"42","key":"6060_CR23","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1093\/eurheartj\/eht241","volume":"34","author":"M Nakano","year":"2013","unstructured":"Nakano M, Otsuka F, Yahagi K, et al. Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics. Eur Heart J. 2013;34(42):3304\u201313. https:\/\/doi.org\/10.1093\/eurheartj\/eht241.","journal-title":"Eur Heart J"},{"issue":"23","key":"6060_CR24","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/circulationaha.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736\u201347. https:\/\/doi.org\/10.1161\/circulationaha.110.009449.","journal-title":"Circulation"},{"issue":"11","key":"6060_CR25","first-page":"567","volume":"25","author":"N Gilis-Siek","year":"2013","unstructured":"Gilis-Siek N, Fijalkowski M, Jaguszewski M, et al. Major adverse cardiovascular events after drug-eluting stent implantation in patients with single chronic total occlusion: a single-center registry. J Invasive Cardiol. 2013;25(11):567\u201372.","journal-title":"J Invasive Cardiol"},{"issue":"3","key":"6060_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"GW Stone","year":"2004","unstructured":"Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221\u201331. https:\/\/doi.org\/10.1056\/NEJMoa032441.","journal-title":"N Engl J Med"},{"issue":"1","key":"6060_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5334\/gh.1112","volume":"17","author":"R Kumar","year":"2022","unstructured":"Kumar R, Ammar A, Saghir T, et al. Incidence, predictors, and outcomes of acute and sub-acute stent thrombosis after emergency percutaneous coronary revascularization with drug-eluting stents: a prospective observational study. Glob Heart. 2022;17(1):24. https:\/\/doi.org\/10.5334\/gh.1112. Published Online First: 20220330.","journal-title":"Glob Heart"},{"key":"6060_CR28","doi-asserted-by":"publisher","first-page":"1647635","DOI":"10.1155\/2021\/1647635","volume":"2021","author":"X Wu","year":"2021","unstructured":"Wu X, Li L, He L. Drug-coated balloon versus drug-eluting stent in patients with small-vessel coronary artery disease: a meta-analysis of randomized controlled trials. Cardiol Res Pract. 2021;2021:1647635. https:\/\/doi.org\/10.1155\/2021\/1647635.","journal-title":"Cardiol Res Pract"},{"issue":"6","key":"6060_CR29","doi-asserted-by":"publisher","first-page":"e0234362","DOI":"10.1371\/journal.pone.0234362","volume":"15","author":"CH Lee","year":"2020","unstructured":"Lee CH, Choi SW, Jun SW, et al. Clinical impact of diabetes mellitus on 2-year clinical outcomes following PCI with second-generation drug-eluting stents; landmark analysis findings from patient registry: pooled analysis of the Korean multicenter drug-eluting stent registry. PLoS ONE. 2020;15(6):e0234362. https:\/\/doi.org\/10.1371\/journal.pone.0234362. Published Online First: 20200610.","journal-title":"PLoS ONE"},{"issue":"2","key":"6060_CR30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jdiacomp.2017.10.016","volume":"32","author":"S Kou","year":"2018","unstructured":"Kou S, Cao JY, Yeo S, et al. Ethnicity influences cardiovascular outcomes and complications in patients with type 2 diabetes. J Diabetes Complicat. 2018;32(2):144\u201349. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.10.016.","journal-title":"J Diabetes Complicat"},{"key":"6060_CR31","doi-asserted-by":"publisher","unstructured":"Onuma Y, Kimura T, R\u00e4ber L et al. Differences in coronary risk factors, procedural characteristics, mortality and stent thrombosis between two all-comers percutaneous coronary intervention registries from Europe and Japan: a patient-level data analysis of the Bern-Rotterdam and j-Cypher registries. EuroIntervention 2015;11(5):533\u2009\u2013\u200940. https:\/\/doi.org\/10.4244\/eijy14m06_09.","DOI":"10.4244\/eijy14m06_09"},{"issue":"25","key":"6060_CR32","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/j.jacc.2010.10.006","volume":"56","author":"DJ Kereiakes","year":"2010","unstructured":"Kereiakes DJ, Cutlip DE, Applegate RJ, et al. Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System). J Am Coll Cardiol. 2010;56(25):2084\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2010.10.006.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"6060_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12928-017-0458-9","volume":"33","author":"K Nakatsuma","year":"2018","unstructured":"Nakatsuma K, Shiomi H, Natsuaki M, et al. Second-generation versus first-generation drug-eluting stents in patients with and without diabetes mellitus: pooled analysis from the RESET and NEXT trials. Cardiovasc Interv Ther. 2018;33(2):125\u201334. https:\/\/doi.org\/10.1007\/s12928-017-0458-9. Published Online First: 20170201.","journal-title":"Cardiovasc Interv Ther"},{"issue":"17","key":"6060_CR34","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jacc.2009.01.050","volume":"53","author":"G Weisz","year":"2009","unstructured":"Weisz G, Leon MB, Holmes DR Jr., et al. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial. J Am Coll Cardiol. 2009;53(17):1488\u201397. https:\/\/doi.org\/10.1016\/j.jacc.2009.01.050.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"6060_CR35","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"I Iakovou","year":"2005","unstructured":"Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126\u201330. https:\/\/doi.org\/10.1001\/jama.293.17.2126.","journal-title":"JAMA"},{"issue":"31","key":"6060_CR36","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","volume":"34","author":"F Paneni","year":"2013","unstructured":"Paneni F, Beckman JA, Creager MA, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34(31):2436\u201343. https:\/\/doi.org\/10.1093\/eurheartj\/eht149. Published Online First: 20130502.","journal-title":"Eur Heart J"},{"issue":"6","key":"6060_CR37","doi-asserted-by":"publisher","first-page":"e004792","DOI":"10.1161\/CIRCINTERVENTIONS.117.004792","volume":"10","author":"D-W Park","year":"2017","unstructured":"Park D-W, Park S-J. Percutaneous coronary intervention of left main disease. Circulation: Cardiovasc Interventions. 2017;10(6):e004792. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.004792.","journal-title":"Circulation: Cardiovasc Interventions"},{"issue":"11","key":"6060_CR38","doi-asserted-by":"publisher","first-page":"e20240202","DOI":"10.36660\/abc.20240202","volume":"121","author":"A \u00d6z","year":"2024","unstructured":"\u00d6z A, Toprak K, Aydin E, et al. Fixed-dose antiplatelet dual combination in patients with coronary artery disease in Turkish population: DAPT-TR. Arq Bras Cardiol. 2024;121(11):e20240202. https:\/\/doi.org\/10.36660\/abc.20240202.","journal-title":"Arq Bras Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06060-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06060-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06060-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:05:43Z","timestamp":1788779143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06060-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6060"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06060-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The collection and use of human samples in this study were performed in compliance with all relevant guidelines and regulations, including the Declaration of Helsinki. This study was approved by the Shanghai Ethics Committee for Clinical Research. The requirement for written informed consent from participants was waived by the Shanghai Ethics Committee for Clinical Research.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"772"}}